For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
News Release
EPA Makes Right Decision on Use of Human Volunteers in Pesticide Safety Studies
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Contact: Jody Clarke, 202.331.2252 <?xml:namespace prefix…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. INTERNET A major computer hacker pleads guilty in federal court to hijacking hundreds of thousands of…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY The Food and Drug Administration approves fat-blocking drug Xenical for over-the-counter sales.
Op-Eds
How Roe Destroyed Privacy
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY The World Health Organization raises concerns about resistance to a key…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY The Food and Drug Administration announces new guidelines for prescription drug…